Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115937) titled 'SGLT-2 Inhibitors Combined with Finerenone in Patients with Type 2 Diabetic Kidney Disease: A Real-World Study' on Jan. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai Jing 'an District Central Hospital
Condition:
Type 2 diabetic nephropathy
Intervention:
SGLT-2 inhibitor monotherapy group:None
Combined Medication Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-04
Target Sample Size: SGLT-2 inhibitor monotherapy group:100;Combined Medication Group:100;Finerenone Monotherapy Group:100;
Countries of Recruitment:
China...